Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19

被引:8
|
作者
Chen, Kuang-Den [1 ,2 ,3 ]
Huang, Ying-Hsien [1 ,2 ,4 ]
Wu, Wei-Sheng [5 ]
Chang, Ling-Sai [1 ,2 ,4 ]
Chu, Chiao-Lun [1 ,2 ]
Kuo, Ho-Chang [1 ,2 ,4 ,6 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan
[6] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
kawasaki disease; COVID-19; aged neutrophils; overactivation; single-cell RNA sequencing; CORONARY-ARTERY LESIONS; ACTIVATION; EPICENTER; EPIDEMIC; CELLS;
D O I
10.3389/fimmu.2022.995886
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kawasaki disease (KD), a multisystem inflammatory syndrome that occurs in children, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) may share some overlapping mechanisms. The purpose of this study was to analyze the differences in single-cell RNA sequencing between KD and COVID-19. We performed single-cell RNA sequencing in KD patients (within 24 hours before IVIG treatment) and age-matched fever controls. The single-cell RNA sequencing data of COVID-19, influenza, and health controls were downloaded from the Sequence Read Archive (GSE149689/PRJNA629752). In total, 22 single-cell RNA sequencing data with 102,355 nuclei were enrolled in this study. After performing hierarchical and functional clustering analyses, two enriched gene clusters demonstrated similar patterns in severe COVID-19 and KD, heightened neutrophil activation, and decreased MHC class II expression. Furthermore, comparable dysregulation of neutrophilic granulopoiesis representing two pronounced hyperinflammatory states was demonstrated, which play a critical role in the overactivated and defective aging program of granulocytes, in patients with KD as well as those with severe COVID-19. In conclusion, both neutrophil activation and MHC class II reduction play a crucial role and thus may provide potential treatment targets for KD and severe COVID-19.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] COVID-19 disease and immune dysregulation
    Davitt, Ethan
    Davitt, Colin
    Mazer, Monty B.
    Areti, Sathya S.
    Hotchkiss, Richard S.
    Remy, Kenneth E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
  • [2] Baricitinib restrains the immune dysregulation in patients with severe COVID-19
    Bronte, Vincenzo
    Ugel, Stefano
    Tinazzi, Elisa
    Vella, Antonio
    De Sanctis, Francesco
    Cane, Stefania
    Batani, Veronica
    Trovato, Rosalinda
    Fiore, Alessandra
    Petrova, Varvara
    Hofer, Francesca
    Barouni, Roza Maria
    Musiu, Chiara
    Caligola, Simone
    Pinton, Laura
    Torroni, Lorena
    Polati, Enrico
    Donadello, Katia
    Friso, Simonetta
    Pizzolo, Francesca
    Iezzi, Manuela
    Facciotti, Federica
    Pelicci, Pier Giuseppe
    Righetti, Daniela
    Bazzoni, Paolo
    Rampudda, Mariaelisa
    Comel, Andrea
    Mosaner, Walter
    Lunardi, Claudio
    Olivieri, Oliviero
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (12): : 6409 - 6416
  • [3] Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
    Giamarellos-Bourboulis, Evangelos J.
    Netea, Mihai G.
    Rovina, Nikoletta
    Akinosoglou, Karolina
    Antoniadou, Anastasia
    Antonakos, Nikolaos
    Damoraki, Georgia
    Gkavogianni, Theologia
    Adami, Maria-Evangelia
    Katsaounou, Paraskevi
    Ntaganou, Maria
    Kyriakopoulou, Magdalini
    Dimopoulos, George
    Koutsodimitropoulos, Ioannis
    Velissaris, Dimitrios
    Koufargyris, Panagiotis
    Karageorgos, Athanassios
    Katrini, Konstantina
    Lekakis, Vasileios
    Lupse, Mihaela
    Kotsaki, Antigone
    Renieris, George
    Theodoulou, Danai
    Panou, Vassiliki
    Koukaki, Evangelia
    Koulouris, Nikolaos
    Gogos, Charalambos
    Koutsoukou, Antonia
    CELL HOST & MICROBE, 2020, 27 (06) : 992 - +
  • [4] Immune Characteristic Genes and Neutrophil Immune Transformation Studies in Severe COVID-19
    Zhou, Zhaoming
    Zeng, Xin
    Liao, Jing
    Dong, Xinfeng
    Deng, Yinyun
    Wang, Yinghui
    Zhou, Meijuan
    MICROORGANISMS, 2024, 12 (04)
  • [5] Severe refractory Kawasaki disease in seven infants in the COVID-19 era
    Vergnano, Stefania
    Alders, Nele
    Armstrong, Catherine
    Bomber, Andrew R.
    Bandi, Srini
    Evans, Jennifer A.
    Hajiani, Nadia
    Kenny, Julia
    Kucera, Filip
    Tometzki, Andrew
    Uzun, Orhan
    Wilkinson, Nick
    Ramanan, Athimalaipet V.
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E520 - E520
  • [6] Neutrophil calprotectin identifies severe pulmonary disease in COVID-19
    Shi, Hui
    Zuo, Yu
    Yalavarthi, Srilakshmi
    Gockman, Kelsey
    Zuo, Melanie
    Madison, Jacqueline A.
    Blair, Christopher N.
    Woodard, Wrenn
    Lezak, Sean P.
    Lugogo, Njira L.
    Woods, Robert J.
    Lood, Christian
    Knight, Jason S.
    Kanthi, Yogendra
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 109 (01) : 67 - 72
  • [7] Impact of COVID-19 infection on Kawasaki disease and immune status in children
    Gao, Lichao
    Xu, Zhufei
    Hu, Jian
    Zhang, Qing
    Fu, Songling
    Wang, Wei
    Xie, Chunhong
    Zhang, Yiying
    Wang, Yujia
    Gong, Fangqi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] Localized immune dysregulation is associated with lung injury in severe pediatric COVID-19
    Korenberg, Rebecca C.
    Bell, Joseph N.
    Bradley, Marissa C.
    Connors, Thomas J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [9] No relationship was observed between Kawasaki disease and COVID-19 in Japan
    Nakamura, Yosikazu
    PEDIATRICS INTERNATIONAL, 2021, 63 (08) : 977 - 977
  • [10] COVID-19 and Kawasaki disease in children
    Xu, Suowen
    Chen, Mingwu
    Weng, Jianping
    PHARMACOLOGICAL RESEARCH, 2020, 159